<drug xmlns="http://nctr.fda.gov/xdagen">
  <id>2</id>
  <name>Test Drug 2</name>
  <compound_id>2</compound_id>
  <therapeutic_indications>Indication 2</therapeutic_indications>
  <spl>
    <document>
      <gen-name>drug 2</gen-name>
    </document>
  </spl>
  <advisory-listing>
    <advisory>
      <id>201</id>
      <drug_id>2</drug_id>
      <advisory_type_id>1</advisory_type_id>
      <text>Advisory concerning drug 2</text>
    </advisory>
    <advisory>
      <id>202</id>
      <drug_id>2</drug_id>
      <advisory_type_id>2</advisory_type_id>
      <text>Caution concerning drug 2</text>
    </advisory>
  </advisory-listing>
  <brand-listing>
    <brand>
      <drug_id>2</drug_id>
      <brand_name>Brand2(TM)</brand_name>
      <language_code>EN</language_code>
      <manufacturer_id>3</manufacturer_id>
    </brand>
  </brand-listing>
  <drug_functional_category-listing>
    <drug_functional_category>
      <drug_id>2</drug_id>
      <functional_category_id>3</functional_category_id>
      <authority_id>1</authority_id>
      <seq>1</seq>
    </drug_functional_category>
    <drug_functional_category>
      <drug_id>2</drug_id>
      <functional_category_id>6</functional_category_id>
      <authority_id>1</authority_id>
      <seq>2</seq>
    </drug_functional_category>
  </drug_functional_category-listing>
  <drug_reference-listing>
    <drug_reference>
      <drug_id>2</drug_id>
      <reference_id>201</reference_id>
      <priority>2</priority>
    </drug_reference>
    <drug_reference>
      <drug_id>2</drug_id>
      <reference_id>202</reference_id>
      <priority>2</priority>
    </drug_reference>
    <drug_reference>
      <drug_id>2</drug_id>
      <reference_id>203</reference_id>
      <priority>2</priority>
    </drug_reference>
  </drug_reference-listing>
  <compound>
    <id>2</id>
    <display_name>Test Compound 2</display_name>
    <nctr_isis_id>DUMMY2</nctr_isis_id>
  </compound>
</drug>
